Search for: "Takeda Global Research "
Results 1 - 20
of 39
Sorted by Relevance
|
Sort by Date
18 Jan 2012, 8:54 am
Takeda did not research the cause of increased rate of tumor formation, nor did it conduct further studies with human volunteers. [read post]
8 Jan 2012, 9:05 pm
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
11 Jan 2012, 9:44 pm
Takeda International is a global pharmaceutical company headquartered in Japan. [read post]
13 Feb 2015, 1:13 pm
The company folks in Osaka, Japan will have to give serious thought to stop the hemorrhaging of money in the defense of these indefensible bladder cancer cases and go for a global settlement. [read post]
9 Feb 2015, 5:41 pm
Wisniewski and other users allege that Takeda researchers ignored or downplayed concerns about the Actos bladder cancer links before it went on sale in the U.S. and misled U.S. regulators about the diabetic medication risks. [read post]
27 Feb 2015, 6:35 am
The company folks in Osaka, Japan will have to give serious thought to stop the hemorrhaging of money in the defense of these indefensible bladder cancer cases and go for a global settlement. [read post]
25 Oct 2012, 9:20 pm
Consider how common a disease type 2 diabetes is—285 million are afflicted globally—and how many of these people have been prescribed Actos over the years. [read post]
7 Jul 2012, 12:22 pm
Actos is one of Takeda’s top-selling drugs with global sales of $4.8 billion last year; in 2008, Actos was the 10th best -selling medication in the United States. [read post]
7 Jul 2012, 12:22 pm
Actos is one of Takeda’s top-selling drugs with global sales of $4.8 billion last year; in 2008, Actos was the 10th best -selling medication in the United States. [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that would allow generic… [read post]
17 Sep 2011, 5:43 am
The lawsuit alleges that Actos' manufacturer, Takeda Pharmaceuticals North America (and other entities including: Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals Company Ltd., Takeda Pharmaceuticals America, Takeda San Diego Inc., Takeda Pharmaceuticals International Inc and Eli Lilly and Company), was negligent for not providing any warnings regarding the increased bladder cancer risk… [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/6: Takeda Pharmaceutical Company Ltd. and Takeda Pharmaceuticals North America Inc. v. [read post]
5 Apr 2014, 4:25 pm
Thousands of product liability lawsuits have been filed against Takeda Pharmaceuticals and Eli Lilly, the drug mamanufacturers for failure to research the medication and failure to provide sufficient warnings to patients and doctors. [read post]
19 May 2010, 6:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: India and Brazil start WTO dispute proceedings against EU (Spicy IP) (Managing IP) (IP tango) (IP Watch) (Knowledge Ecology International) General The death of gene patents and communication IP value IP Think Tank podcast 1 Apr 2010 (IP Think Tank) Proposals at WHO would boost drug safety, replace… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs)… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs)… [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess… [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Pataday (Olopatadine hydrochloride ophthalmic solution) – US: Patent infringement complaint filed in S D Indiana following a Paragraph IV certification: Alcon Research, Ltd. et al. v. [read post]
